Skip to content
healthcare.dev

Topiramate

NDC 70771-1658, Topiramate, capsule, extended release, from Zydus Lifesciences Limited.

Product NDC
70771-1658
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208949
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1658 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE100 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
70771-1658-37077116580330 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1658-3)
70771-1658-97077116580990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1658-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/57b5d67b-b29b-4c18-a53d-51d5374f3be3

Use it

Look up 70771-1658 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1658 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1658. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.